DAAAK PHARMA INT. AS - 12864378 | ScoreStorybook | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

DAAAK PHARMA INT. AS

Summary report

Date of report 20.01.2025

DAAAK PHARMA INT. AS
12864378 - Registered
Founded in 11.06.2015
Fixed capital 25,000 €

Former names

  • MN Pharm AS
VAT  
EE101908124 (start 16.09.2016)
start end
16.09.2016 -

Add DAAAK PHARMA INT. AS data to your system

download JSON download CSV

Add DAAAK PHARMA INT. AS data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

Don't have CRM? Read more

keywords

  • meditsiiniseadmete hulgimüük

DAAAK PHARMA INT. AS

Scores and ratings

Reputation score

What is Reputation score?

Credit Score

Trustworthy 0.01

Loader

What is Credit Score?

Open the reports you want to print

Employees and salaries

DAAAK PHARMA INT. AS

Number of employees and estimated average salaries
?

DAAAK PHARMA INT. AS

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................

Deciders and beneficiaries

DAAAK PHARMA INT. AS

Decision-makers
?

Former decision-makers

Jelena Lerner

Relations: 4
Turnover 2024: 14 481 494 €
Employees: 6
Jelena Lerner
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 7720

Date of birth: ......

Active relations 4

Wholesale of medical devicesAccountingActivities of housing associationsWholesale trade of various goods
*Every member of the management board may represent the public limited company in concluding all transactions.

DAAAK PHARMA INT. AS

Former decision-makers
?

Valeri Trofimov

Relations: 3
Turnover:
Employees: 1
Valeri Trofimov
★★★★

......

Related companies scores

Credit Score: Trustworthy

Reputation score: 460

Date of birth: ......

Active relations 3

Wholesale trade of various goodsMediation of a variety of goods

Siarhei Kastsian

Relations:
Turnover:
Employees:
Siarhei Kastsian
★★★★

......

Related companies scores

Credit Score: None

Reputation score: None

Date of birth: ......

Active relations 0

Yury Sazonau

Relations:
Turnover:
Employees:
Yury Sazonau
★★★★

......

Related companies scores

Credit Score: None

Reputation score: None

Date of birth: ......

Active relations 0

DAAAK PHARMA INT. AS

History of right of representation
?
Field
Trading
Business age
9y
Beneficial country:
Estonia
 
Jelena Lerner ... - ...
Yury Sazonau ... - ...
Siarhei Kastsian ... - ...
Valeri Trofimov ... - ...
2015
2016
2018
2019
2021
2022
2024
2025
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025

DAAAK PHARMA INT. AS

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
0.01
..................
!
..................
0.01
..................
0.01
..................
0.01
..................
!
..................
0.01
..................
0.01
..................

DAAAK PHARMA INT. AS

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
!
............
0.01
............
!
............
0.01
............
!
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnding
!
..................
!
..................
!
..................
!
..................
!
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.01
..................
0.26
..................
0.01
..................
0.01
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

DAAAK PHARMA INT. AS

Goodwill

DAAAK PHARMA INT. AS

Taxes paid and estimated average salaries

DAAAK PHARMA INT. AS

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................

DAAAK PHARMA INT. AS

Sales revenue by business area

DAAAK PHARMA INT. AS

Sales revenue by country

DAAAK PHARMA INT. AS

Financial indicators and prognosis

DAAAK PHARMA INT. AS

Financial raiting: "VERY GOOD" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

DAAAK PHARMA INT. AS

Annual reports
Year Period Submitted Report PDF
2023 01.01.2023–31.12.2023 17.05.2024 ......
2022 01.01.2022–31.12.2022 27.04.2023 ......
2021 01.01.2021–31.12.2021 05.05.2022 ......
2020 01.01.2020–31.12.2020 14.06.2021 ......
2019 01.01.2019–31.12.2019 30.06.2020 ......
2018 01.01.2018–31.12.2018 25.06.2019 ......
2017 01.01.2017–31.12.2017 26.07.2018 ......
2016 01.01.2016–31.12.2016 14.06.2017 ......
2015 01.01.2015–31.12.2015 10.05.2016 ......

Liabilities and debts

DAAAK PHARMA INT. AS

Credit score history and prognosis
Publish claims
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

DAAAK PHARMA INT. AS

Reports and assets-liabilities overview 20.01.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

DAAAK PHARMA INT. AS

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Private debt ...... €

Total debt claims: ...... €

Latest events
...... ......

DAAAK PHARMA INT. AS

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......

DAAAK PHARMA INT. AS

Bailiff's enforcement proceedings as of 20.01.2025
?

Bailiff's enforcement proceedings MISSING

DAAAK PHARMA INT. AS

Regulations of the Payment Order Department as of 20.01.2025
?

Regulations of the Payment Order Department MISSING

DAAAK PHARMA INT. AS

Court orders in the register as of 20.01.2025
?
Logo

Puuduste kõrvaldamise määrus

02.05.2024

Regulation number: Ä 50009789 / M5

Regulation status has entered into force: 02.05.2024

Date of enforcement of order or additional period: 03.05.2024

Regulation status: Puudused kõrvaldatud

Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

01.04.2024

Regulation number: Ä 50009789 / M4

Regulation status has entered into force: 08.04.2024

Date of enforcement of order or additional period: 01.04.2024

Regulation status: Puudused kõrvaldatud

Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

18.04.2023

Regulation number: Ä 50009789 / M3

Regulation status has entered into force: 20.04.2023

Date of enforcement of order or additional period: 18.04.2023

Regulation status: Puudused kõrvaldatud

Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

11.04.2023

Regulation number: Ä 50009789 / M2

Regulation status has entered into force: 11.04.2023

Date of enforcement of order or additional period: 11.04.2023

Regulation status: Jõustunud

Logo

Puuduste kõrvaldamise määrus

18.09.2020

Regulation number: Ä 50009789 / M1

Regulation status has entered into force: 04.10.2020

Date of enforcement of order or additional period: 18.09.2020

Regulation status: Puudused kõrvaldatud

DAAAK PHARMA INT. AS

Decisions of the Consumer Disputes Committee as of 20.01.2025
?

Consumer disputes MISSING

DAAAK PHARMA INT. AS

Court hearings as of 20.01.2025
?

Court hearings MISSING

DAAAK PHARMA INT. AS

Rulings as of 20.01.2025
?

Court settlemets MISSING

DAAAK PHARMA INT. AS

Notices and announcements as of 20.01.2025
?
Logo

Notice of service of a procedural document in civil proceedings

13.02.2024
Menetlusdokumendi tsiviilkohtumenetluses kättetoimetamise teade
Avaldamise algus: 13.02.2024
Avaldamise lõpp: 14.05.2024
Harju Maakohus Tallinna kohtumaja avaldab teadaande tsiviilkohtumenetluse seadustiku (TsMS) § 317 lõike 3 alusel.

Harju Maakohus Tallinna kohtumaja toimetab võlausaldajale, DAAAK Pharma Int. AS (registrikood: 12864378), avalikult kätte 19.01.2024 kohtumääruse tsiviilasjas 2-20-5056

19.01.2024 kohtumääruse RESOLUTSIOON: 1.Kinnitada GFC Good Finance Company AS (pankrotis) pankrotimenetluses võlausaldajate 16.10.2023 üldkoosolekul vastuvõetud kompromissotsus ning kinnitada kompromissi tingimused käesoleva määruse lisana nr 1.2.Lõpetada GFC Good Finance Company AS (pankrotis, registrikood 12423254) pankrotimenetlus.3.Määrata kompromissi üle järelevalvet teostama pankrotihaldur Toomas Saarma. 4.Kompromissimääruse täitmise järgselt kuulub GFC Good Finance Company AS registrist kustutamisele.5.Vabastada Toomas Saarma GFC Good Finance Company AS (pankrotis) pankrotihalduri kohustustest pärast kompromissist tulenevate kohustuste täitmist.6.Jätta pankrotimenetluse kulud poolte endi kanda.7.Pankrotihalduril avaldada teade kompromissi kinnitamisest väljaandes Ametlikud Teadaanded (PankrS § 183 lg 5).

Dokument on Teile kättesaadav ka avalikus e-toimikus (http://www.e-toimik.ee). Sisenemiseks saab kasutada ID-kaarti või mobiil-ID-d.

Dokument loetakse avalikult kättetoimetatuks 15 päeva möödumisel käesoleva teadaande avaldamisest (TsMS § 317 lg 5).
 
Harju Maakohus Tallinna kohtumaja
Kesklinna linnaosa, Tallinn, Harju maakond 10115, Lubja 4
Telefon: 6200100
E-post: hmktallinn.menetlus@kohus.ee
Teadaande number 2220445

Marketing

Business network

DAAAK PHARMA INT. AS

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

DAAAK PHARMA INT. AS

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.